- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Latest Articles in Moderna
AstraZeneca Has Sold Its Stake In Moderna For More Than $1 Billion
AstraZeneca is retaining partnership with Moderna on other disease treatments and could sell its AstraZeneca/Oxford University COVID-19 vaccine on a commercial basis in future if the virus becomes endemic
Read MoreAstraZeneca Has Sold Its Stake In Moderna For More Than $1 billion
The report added that it was not clear over what period British-based AstraZeneca sold its holding in Moderna.
Read MoreModerna Expects $18.4 Billion In COVID-19 Vaccine Sales In 2021
Pfizer earlier this month forecast $15 billion in its share of sales from the COVID-19 vaccine it developed jointly with partner BioNTech.
Read MorePfizer, Moderna vaccines can protect against coronavirus variant: Study
Pfizer, Moderna vaccines can protect against coronavirus variant: Study
Read MoreUS secures 200 more doses of Moderna, Pfizer vaccines
US secures 200 more doses of Moderna, Pfizer vaccines
Read MoreFrance to start rollout of AstraZeneca vaccine on weekend - Health Minister
France to start rollout of AstraZeneca vaccine on weekend - Health Minister
Read MoreJ&J Vaccine Adds To COVID-19 Armoury, Includes South African Variant
J&J shares were down 4% at $162.7 at 1700 GMT, with some Wall Street analysts saying its vaccine's effectiveness was below those of rivals. Moderna's stock gained 8% to $172.80.
Read MoreLonza Says Production For Moderna At Two New Swiss Lines To Start 'Soon'
"We expect that within a couple of months, we will reach cruising speed," Ruffieux told reporters on a conference call on Wednesday, without giving a firm timeline for when all three new production lines supplying Moderna will be at their full capacity and making ingredients for roughly 300 million vaccine doses annually.
Read MoreModerna says its COVID-19 vaccine demonstrates 'neutralising impact' on new variants
Moderna says its COVID-19 vaccine demonstrates 'neutralising impact' on new variants
Read MoreTata In Talks To Launch Moderna COVID-19 Vaccine In India
Tata could team up with the India's Council of Scientific & Industrial Research (CSIR) to carry out clinical trials of Moderna's vaccine candidate in India
Read MoreSwitzerland authorizes Moderna's Covid-19 vaccine for immediate use
Switzerland authorizes Moderna's Covid-19 vaccine for immediate use
Read MoreSpain receives first batch of Moderna COVID-19 vaccine
Spain receives first batch of Moderna COVID-19 vaccine
Read MoreSpain to receive 1st batch of Moderna vaccine in 7-10 days: Health Minister
Spain to receive 1st batch of Moderna vaccine in 7-10 days: Health Minister
Read MoreModerna To Produce At Least 600 Million Doses Of COVID-19 Vaccine In 2021
Moderna said it is continuing to invest and add staff to build up to potentially 1 billion doses for 2021
Read MoreExperts, politicians slam Germany for not buying adequate coronavirus vaccine doses
Experts, politicians slam Germany for not buying adequate coronavirus vaccine doses
Read More